IndraLab

Statements

USP22 deacetylates XRCC6. 7 / 7
| 7
reach
"USP22 can reduce Ku70 acetylation by stabilizing SIRT1 expression, thereby inhibiting Bax-mediated apoptosis and promoting cisplatin resistance.ALDH1A3, a major ALDH isoenzyme, is important for the stem cell signature of lung cancer and is associated with enhanced cisplatin resistance in lung adenocarcinoma."
35935969
reach
"USP22 Decreases the Acetylation of Ku70 by Stabilizing Sirt1, thus Inhibiting Bax Mediated Apoptosis and Inducing Cisplatin Resistance."
28567015
reach
"In addition, USP22 could also decrease the acetylation of Ku70 by stabilizing the expression of Sirt1, thus inhibiting Bax mediated apoptosis and contributing to cisplatin resistance."
28567015
reach
"These results suggest that USP22 decreases the acetylation of Ku70 by stabilizing Sirt1, thus inhibiting Bax mediated apoptosis and inducing cisplatin resistance."
28567015
reach
"(2) USP22 decreases the acetylation of Ku70 by stabilizing Sirt1, thus inhibiting Bax mediated apoptosis and inducing cisplatin resistance."
28567015
reach
"In addition, USP22 decreases the acetylation of Ku70 by stabilizing Sirt1, thus inhibiting Bax mediated apoptosis and inducing cisplatin resistance."
28567015
reach
"In addition, USP22 was shown to decrease the acetylation of Ku70 by stabilizing SIRT11 via deubiquitination."
34660907